Viemed Healthcare, Inc. VMD
8.91
0.09
1.02%
as of 25 Sep
- Market cap
- $335.9M
- P/E
- 23.4×
Follow VMD
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
10.38% | 10.79% | 10.54% | 10.08% | |
| 7.32% | 7.94% | 7.93% | 7.46% | ||
ROIC |
7.35% | 8.98% | 10.19% | 10.66% | |
Return on Tangible Assets |
15.77% | 17.32% | 17.50% | 17.42% | |
Average Days of Receivables |
42.01 | 34.86 | 39.71 | 39.00 | |
Free Cash Flow per Share |
0.60 | 0.72 | 0.95 | 0.90 | |
Free Cash Flow |
23.29 | 28.08 | 36.34 | 34.43 | |
Capital Expenditures |
(25.17) | (23.83) | (20.79) | (26.35) | |
Piotroski F-Score |
5.00 | 5.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
28.89% | 30.65% | 34.68% | 37.12% | |
Accounts Receivable Turnover |
9.04 | 10.66 | 9.89 | 10.26 | |
Accounts Payable Turnover |
14.62 | 18.15 | 14.72 | 13.34 | |
Inventory Turnover |
22.40 | 24.52 | 25.08 | 26.75 | |
Average Days of Payables |
29.49 | 23.31 | 25.75 | 31.26 | |
Days of Inventory on Hand |
17.92 | 16.04 | 15.56 | 14.99 | |
Tax Rate |
(0.30) | (0.29) | (0.30) | (0.29) | |
Research and Development Expense of Revenue |
1.26% | 1.12% | 0.98% | 0.81% | |
Selling, General and Administrative Expense of Revenue |
49.34% | 48.28% | 47.81% | 48.08% | |
Share Based Compensation of Revenue |
3.28% | 3.38% | 3.24% | 2.97% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
3.56 | 3.48 | 3.84 | 4.19 | |
Depreciation/Fixed assets |
0.34 | 0.37 | 0.39 | 0.40 | |
Capex/Depreciation |
(0.91) | (0.83) | (0.70) | (0.86) | |
Revenue per Share |
6.59 | 6.95 | 7.46 | 7.89 | |
Operating CF per Share |
1.25 | 1.33 | 1.49 | 1.59 | |
Capex per Share |
(0.65) | (0.61) | (0.54) | (0.69) | |
Capex to Sales |
0.10 | 0.09 | 0.07 | 0.09 | |
Net Profit Margin |
5.34% | 5.53% | 5.20% | 4.81% |
Columns are period end dates